Energy Efficiency, GHG Emissions, Industrial  -  September 23, 2024

Kenvue Lowers Emissions By 26%

Kenvue Inc., the manufacturer of brands such as Aveeno®, Listerine®, Neutrogena® and Tylenol®, achieved progress on its climate change goals; its investments in energy efficiency and decarbonization projects have resulted in Scope 1 and 2 GHG reductions of 26% since 2020.

The company also announced that 21% of its suppliers, by emissions covering purchased goods and services and upstream transportation and distribution, have science-based targets.

Kenvue’s use of renewable electricity has increased to 65% of its electricity usage through 18 onsite solar-powered electricity systems, off-site renewable electricity procurement contracts, and the addition of onsite solar installations.

Since the beginning of 2024, Kenvue completed new onsite solar installations at its Sezanne, France, and Madra, Greece manufacturing sites, which will provide 1.75MW and 0.186MW of renewable energy, respectively. The company also expects to complete additional onsite solar installations at its Cape Town, South Africa, Minhang, China, and Jakarta, Indonesia manufacturing sites this year, further advancing progress toward its goal of achieving 100% renewable electricity for its operations by 2030.

Kenvue has also joined the Energize program, which is designed to help suppliers learn about renewable electricity and provide sourcing opportunities.

Details were provided in the Healthy Lives Mission 2023 Report.

“We have made meaningful progress, including the validation of our near-term greenhouse gas (GHG) emissions reduction targets by the Science Based Targets initiative (SBTi) and the release of our inaugural Healthy Lives Mission report in support of our ambition to help contribute to a healthier future," said Pamela Gill-Alabaster, Global Head of ESG & Sustainability at Kenvue, in a statement.

Share this valuable information with your colleagues using the buttons below: